STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials

This STAT+ article features an interview with Daphne Koller, founder of AI biotech Insitro, discussing strategies for accelerating clinical trials. The piece highlights how AI approaches can address inefficiencies in trial design, patient recruitment, and data analysis, though specific examples or results are not included in the excerpt.